White et al, Biochem. & Biophys. Research Communications, 150(2):615-625, (1988). |
McDowell, Virology, 161:37-44 (1987). |
Myc et al, Cancer Research, 49:2879-83, (Jun. 1, 1989). |
Winkler et al, J. Med. Chem, 32:2084-89, (1989). |
Dennis, Cancer Research, 46:5131-6, (Oct. 1986). |
Farr et al, Tetrahedron Letters, 31(49):7109-7112, (1990). |
Inhibition of Metastatic Potential by Fucosidase: An NMR Study Identifies a Cell Surface Metastasis Marker, Wright et al, Journal of Cellular Biochemistry 37:49-59 (1988). |
Increased Serum .alpha.-L-Fucosidase and .beta.-N-Acetyglucosaminidase Activities in Diabetic, Cirrhotic and Gastric Cancer Patients; Reglero et al., Clinica Chmiica Acta, 103 (1980) 155-158. |
Mechanism of Inhibition of Jack Bean .alpha.-Mannosidase by Swainsonine; Kang et al., Plant Physiol. (1983) 71:551-554. |
Serum .alpha.-L-Fucosidase: A New Marker for the Diagnosis of Primary Hepatic Carcinoma? Deugnier, et al., Hepatology, vol. 4, No. 5, 889-892, 1984. |
A Spectroscopic Investigation of Swainsonine: an .alpha.-Mannosidase Inhibitor Isolated from Swainsona canescens, Colegate, et al., Aust. J. Chem., 1979, 32:2257-64. |
Studies of an Immunomodulator, Swainsonine, I. Hino et al., The Journal of Antibiotics, vol. XXXVII, No. 7, pp. 926-935. |
Studies of an Immunomodulator, Swainsonine, II. Hino et al., The Journal of Antibiotics, vol. XXXVII, No. 7, pp. 936-940. |
Biosynthesis, Meth. Enzymol. 179 (1989) p. 468. |
Tetrahedron Letters, vol. 31, No. 49, pp. 7109-7112 (1990), Farr et al. |
Bernet et al., Helvetica Chimica Acta 62, Fasc. 7 (1979) NR. 245, pp. 2400-2410. |